These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32510949)

  • 1. Leucinostatins from
    Kil YS; Risinger AL; Petersen CL; Mooberry SL; Cichewicz RH
    J Nat Prod; 2020 Jun; 83(6):2010-2024. PubMed ID: 32510949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective activity of deguelin identifies therapeutic targets for androgen receptor-positive breast cancer.
    Robles AJ; Cai S; Cichewicz RH; Mooberry SL
    Breast Cancer Res Treat; 2016 Jun; 157(3):475-88. PubMed ID: 27255535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leucinostatin Y: A Peptaibiotic Produced by the Entomoparasitic Fungus Purpureocillium lilacinum 40-H-28.
    Momose I; Onodera T; Doi H; Adachi H; Iijima M; Yamazaki Y; Sawa R; Kubota Y; Igarashi M; Kawada M
    J Nat Prod; 2019 May; 82(5):1120-1127. PubMed ID: 31017786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to mTOR and PI3K inhibitors in enzalutamide-resistant luminal androgen receptor triple-negative breast cancer patient-derived xenografts.
    Coussy F; Lavigne M; de Koning L; Botty RE; Nemati F; Naguez A; Bataillon G; Ouine B; Dahmani A; Montaudon E; Painsec P; Chateau-Joubert S; Laetitia F; Larcher T; Vacher S; Chemlali W; Briaux A; Melaabi S; Salomon AV; Guinebretiere JM; Bieche I; Marangoni E
    Theranostics; 2020; 10(4):1531-1543. PubMed ID: 32042320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on peptide antibiotics, leucinostatins. II. The structures of leucinostatins A and B.
    Fukushima K; Arai T; Mori Y; Tsuboi M; Suzuki M
    J Antibiot (Tokyo); 1983 Dec; 36(12):1613-30. PubMed ID: 6662805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-Activity Relationships of New Natural Product-Based Diaryloxazoles with Selective Activity against Androgen Receptor-Positive Breast Cancer Cells.
    Robles AJ; McCowen S; Cai S; Glassman M; Ruiz F; Cichewicz RH; McHardy SF; Mooberry SL
    J Med Chem; 2017 Nov; 60(22):9275-9289. PubMed ID: 29053266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on peptide antibiotics, leucinostatins. I. Separation, physico-chemical properties and biological activities of leucinostatins A and B.
    Fukushima K; Arai T; Mori Y; Tsuboi M; Suzuki M
    J Antibiot (Tokyo); 1983 Dec; 36(12):1606-12. PubMed ID: 6662804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple molecular subtypes of triple-negative breast cancer critically rely on androgen receptor and respond to enzalutamide in vivo.
    Barton VN; D'Amato NC; Gordon MA; Lind HT; Spoelstra NS; Babbs BL; Heinz RE; Elias A; Jedlicka P; Jacobsen BM; Richer JK
    Mol Cancer Ther; 2015 Mar; 14(3):769-78. PubMed ID: 25713333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chrysosplenol d, a Flavonol from
    Lang SJ; Schmiech M; Hafner S; Paetz C; Werner K; El Gaafary M; Schmidt CQ; Syrovets T; Simmet T
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32521698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual inhibitory effects of the peptide antibiotics leucinostatins on oxidative phosphorylation in mitochondria.
    Shima A; Fukushima K; Arai T; Terada H
    Cell Struct Funct; 1990 Feb; 15(1):53-8. PubMed ID: 2140298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of palbociclib with enzalutamide shows in vitro activity in RB proficient and androgen receptor positive triple negative breast cancer cells.
    Liu CY; Lau KY; Hsu CC; Chen JL; Lee CH; Huang TT; Chen YT; Huang CT; Lin PH; Tseng LM
    PLoS One; 2017; 12(12):e0189007. PubMed ID: 29261702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype.
    Gerratana L; Basile D; Buono G; De Placido S; Giuliano M; Minichillo S; Coinu A; Martorana F; De Santo I; Del Mastro L; De Laurentiis M; Puglisi F; Arpino G
    Cancer Treat Rev; 2018 Jul; 68():102-110. PubMed ID: 29940524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, Characterization, and Inhibition of Hyaluronic Acid Oligosaccharides in Triple-Negative Breast Cancer.
    Han W; Song L; Wang Y; Lv Y; Chen X; Zhao X
    Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31480599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leucinostatin A inhibits prostate cancer growth through reduction of insulin-like growth factor-I expression in prostate stromal cells.
    Kawada M; Inoue H; Ohba S; Masuda T; Momose I; Ikeda D
    Int J Cancer; 2010 Feb; 126(4):810-8. PubMed ID: 19795463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGFR3 signaling and function in triple negative breast cancer.
    Chew NJ; Nguyen EV; Su SP; Novy K; Chan HC; Nguyen LK; Luu J; Simpson KJ; Lee RS; Daly RJ
    Cell Commun Signal; 2020 Jan; 18(1):13. PubMed ID: 31987043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid chromatography-tandem mass spectrometry characterization of five new leucinostatins produced by Paecilomyces lilacinus CG-189.
    Martinez AF; Moraes LA
    J Antibiot (Tokyo); 2015 Mar; 68(3):178-84. PubMed ID: 25182486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging features of triple-negative breast cancers according to androgen receptor status.
    Candelaria RP; Adrada BE; Wei W; Thompson AM; Santiago L; Lane DL; Huang ML; Arribas EM; Rauch GM; Symmans WF; Gilcrease MZ; Huo L; Lim B; Ueno NT; Moulder SL; Yang WT
    Eur J Radiol; 2019 May; 114():167-174. PubMed ID: 31005169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biosynthesis of Antibiotic Leucinostatins in Bio-control Fungus Purpureocillium lilacinum and Their Inhibition on Phytophthora Revealed by Genome Mining.
    Wang G; Liu Z; Lin R; Li E; Mao Z; Ling J; Yang Y; Yin WB; Xie B
    PLoS Pathog; 2016 Jul; 12(7):e1005685. PubMed ID: 27416025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor Activity of Vanicoside B Isolated from
    Kim D; Wang CY; Hu R; Lee JY; Luu TT; Park HJ; Lee SK
    J Nat Prod; 2019 Nov; 82(11):3140-3149. PubMed ID: 31622095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-β plays a vital role in triple-negative breast cancer (TNBC) drug-resistance through regulating stemness, EMT and apoptosis.
    Xu X; Zhang L; He X; Zhang P; Sun C; Xu X; Lu Y; Li F
    Biochem Biophys Res Commun; 2018 Jul; 502(1):160-165. PubMed ID: 29792857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.